Canlyniadau Chwilio - Jan Ilkowski

  • Dangos 1 - 5 canlyniadau o 5
Mireinio'r Canlyniadau
  1. 1
    APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer’s disease

    APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer’s disease gan Michał Prendecki, Jolanta Florczak-Wyspiańska, Marta Kowalska, Jan Ilkowski, Teresa Grzelak, Katarzyna Bialas, Wojciech Kozubski, Jolanta Dorszewska

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Efficacy and safety of abobotulinumtoxinA in spastic lower limb

    Efficacy and safety of abobotulinumtoxinA in spastic lower limb gan Jean‐Michel Graciès, Alberto Esquenazi, Allison Brashear, Marta Banach, Serdar Koçer, Robert Jech, Svetlana Khatkova, Ján Benetin, Michele Vecchio, Peter McAllister, Jan Ilkowski, Stanisław Ochudlo, F. Catus, Anne Sophie Grandoulier, Claire Vilain, Philippe Picaut, Steven Faux, John Olver, Senén González, Ian Baguley, Katya Kotschet, John Estell, Thierry Deltombe, Thierry Lejeune, Robert Jech, Jean‐Michel Graciès, Alfons Schnitzler, Pierre Decavel, Philippe Marque, F. Boyer, Marie-Ève Isner-Horobeti, Claude Desnuelles, Zoltán Dénes, Attila Csányi, Gábor Fazekas, Katalin Guba, Michele Vecchio, Ugo Dimanico, Giacomo P. Comi, Marta Banach, Monika Rudzińska, Anna Kaminśka, Jan Ilkowski, Stanisław Ochudlo, Małgorzata Krawczyk, Jorge Jacinto, Fernando Parada, Svetlana Khatkova, A A Skoromets, Sofia Timerbaeva, Ján Benetin, Peter Valkovič, Serdar Koçer, Allison Brashear, Alberto Esquenazi, Steven R. Edgley, David M. Simpson, Michael W. O’Dell, Gerard E. Francisco, Erika Driver Dunckley, Peter McAllister, Jeffrey B. Gross, Peter Hedera, Heather W. Walker, Fatma Gül, Bruce Rubin, Ziyad Ayyoub, Stuart Isaacson, Michael Wimmer, James P. Sutton

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet

    Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet gan Cecília Monteiro, Balázs István Tóth, Flávia Brunstein, Ashwini Bobbala, Seema Datta, Ryan Ceniceros, Sandra Sanabria Bohórquez, Veronica G. Anania, Kristin R. Wildsmith, Stephen Schauer, Julie Lee, Michael Dolton, Vidya Ramakrishnan, Daniel Abramzon, Edmond Teng, Puja Aggarwal, Marc Agronin, A. Thomas, Jennifer Arnold, Thomas Arnold, Miquel Baquero Toledo, Rafael Blesa González, Merçé Boada, Wendy Bond, Mark Brody, Mathieu Ceccaldi, Maciej Czarnecki, Antonio Del Olmo Rodriguez, Jacek Dobryniewski, Bruno Dubois, Keith R. Edwards, Concetta Forchetti, Larry B. Goldstein, Ira Goodman, Roxana Hanta Cezara, Jan Ilkowski, William Justiz, Pierre Krolak‐Salmon, Jerzy Krupiński, Lamberto Landete Pascual, Richard Levy, A. Lleó Bisa, Scott Losk, Orlando Maldonado-Robles, Gad A. Marshall, Walter Martínez, Peter McAllister, William Alvin McElveen, Scott McGinnis, Anatol Mickielewicz, Hélène Mollion, Cynthia Murphy, Anil K. Nair, M. T. S. Nair, Omid Omidvar, Nader Oskooilar, Paayal Patel, Anton P. Porsteinsson, Marcin Ratajczak, Meghan Riddle, Michael Rosenbloom, David Russell, Stephen Salloway, Raquel Sanchez Del Valle Diaz, Sharon Sha, Raj C. Shah, Sanjiv Sharma, William B. Smith, Anil K. Sood, Lee Stein, John Stoukides, Stephen Thein, David Watson, David Weisman, Marzena Zboch, Tomasz Zieliński

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label... gan Raju Kapoor, Pei‐Ran Ho, Nolan Campbell, Ih Chang, Aaron Deykin, Fiona Forrestal, Nisha Lucas, Bei Yu, Douglas L. Arnold, Mark S. Freedman, Myla Goldman, Hans-Peter Hartung, Eva Havrdová, Douglas Jeffery, A Miller, Finn Sellebjerg, Diego Cadavid, Dan Mikol, Deborah Steiner, E Bartholomé, Marie D’hooghe, Massimo Pandolfo, Bart Van Wijmeersch, Virender Bhan, Gregg Blevins, Donald Brunet, Virginia Devonshire, Pierre Duquette, Mark S. Freedman, François Grand’Maison, François Jacques, Yves Lapierre, Liesly Lee, Sarah A. Morrow, Michael Yeung, Michal Dufek, Eva Havrdová, Petr Kaňovský, Ivana Štětkářová, Marika Talábová, Jette Lautrup Frederiksen, Matthias Kant, Thor Petersen, Mads Ravnborg, Finn Sellebjerg, Laura Airas, Irina Elovaara, Juha-Pekka Erälinna, Taneli Sarasoja, Abdullatif Al Khedr, David Brassat, Bruno Brochet, William Camu, Marc Debouverie, David Laplaud, Christine Lebrun‐Frénay, Jean Pelletier, Patrick Vermersch, Sandra Vukusi, Karl Baum, Achim Berthele, Juergen Faiss, Peter Flachenecker, Reinhard Hohlfeld, Markus Krumbholz, Christoph Lassek, Markus Maeurer, Sven G. Meuth, Tjalf Ziemssen, Orla Hardiman, Christopher McGuigan, Anat Achiron, Dimitrios Karussis, Roberto Bergamaschi, Vincenzo Brescia Morra, Giancarlo Comi, Salvatore Cottone, Luigi M.E. Grimaldi, Gianluigi Mancardi, Luca Massacesi, Ugo Nocentini, Marco Salvetti, Elio Scarpini, Patrizia Sola, Gioacchino Tedeschi, María Trojano, Mauro Zaffaroni, Stephan Frequin, Raymond Hupperts, Joep Killestein, Hans M. Schrijver, Ronald Van Dijl, Erik van Munster, Maciej Czarnecki, Wiesław Drozdowski, Waldemar Fryze, Hanka Hertmanowska, Jan Ilkowski, Anna Kaminśka, Gabriela Kłodowska-Duda

    Cyhoeddwyd 2018
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease

    Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease gan Edmond Teng, Paul T. Manser, Karen Pickthorn, Flávia Brunstein, Mira Blendstrup, Sandra Sanabria Bohórquez, Kristin R. Wildsmith, Bali Toth, Michael Dolton, Vidya Ramakrishnan, Ashwini Bobbala, Sietske A.M. Sikkes, Michael E. Ward, Reina N. Fuji, Geoffrey A. Kerchner, Peter Farnbach, Chris Kyndt, Terence J. O’Brien, Nawaf Yassi, Raymond Schwartz, Siddhartha Lieten, Rik Vandenberghe, F. Vanhee, Richard Bergeron, Sandra E. Black, Sharon Cohen, Andrew Frank, William Nisker, Maria Carmela Tartaglia, Annette Justesen, Peter Alexandersen, Søren Nielsen, A. Areovimata, Pierre Anthony, Serge Belliard, Frédéric Blanc, Mathieu Ceccaldi, Bruno Dubois, Pierre Krolak‐Salmon, Hélène Mollion, Florence Pasquier, Timo Grimmer, Monika Elisabeth Kottke-Arbeiter, Christoph Laske, Oliver Peters, D Polívka, Christine A. F. Von Arnim, Giuseppe Bruno, Carlo de Lena, Emanuele Cassetta, Diego Centonze, Giancarlo Logroscino, P. L. J. Dautzenberg, Sterre Malou Rutgers, Niels D. Prins, Maciej Czarnecki, Jacek Dobryniewski, Jan Ilkowski, Gabriela Klodowska, Anna Krygowska‐Wajs, Robert Kucharski, Anatol Mickielewicz, Marcin Ratajczak, Marzena Zboch, Tomasz Zieliński, Pedro Abizanda, Eduardo Agüera, Miquel Baquero Toledo, Rafael Blesa González, Merçé Boada, Antonio Del Olmo Rodriguez, Jerzy Krupiński, Gurutz Linazasoro Cristóbal, Jesus Arrieta, Mario Riverol Fernandez, Raquel Sanchez Del Valle Diaz, Félix Viñuela Fernandez, Michael Jonsson, Henrik Östlund, Josephine Emer MacSweeney, Catherine J. Mummery, Marc Agronin, A. Thomas, Wendy Bond, Frederick W. Schaerf, Mark Brody, Keith R. Edwards, Concetta Forchetti, Anil K. Sood, David Geldmacher, Larry B. Goldstein, Ira Goodman, David Hart, Lawrence S. Honig, William Justiz, Allan I. Levey, Scott Losk, Gad A. Marshall, Walter Martínez, Peter McAllister

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: